| scholarly article | Q13442814 |
| P2093 | author name string | Roberto Gianni-Barrera | |
| Michael Heberer | |||
| Andrea Banfi | |||
| Philipp Fueglistaler | |||
| Edin Mujagic | |||
| Heidi Misteli | |||
| Lorenz Gurke | |||
| Thomas Wolff | |||
| Uta Helmrich | |||
| P2860 | cites work | Angiogenesis in health and disease | Q29614541 |
| Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy | Q34086442 | ||
| Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials | Q35982220 | ||
| Arteriogenesis versus angiogenesis: similarities and differences | Q36430853 | ||
| Partitioning locomotor energy use among and within muscles. Muscle blood flow as a measure of muscle oxygen consumption | Q36513599 | ||
| Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy | Q36534906 | ||
| An update on angiogenic gene therapy: vascular endothelial growth factor and other directions. | Q36586713 | ||
| Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine | Q36756406 | ||
| Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor | Q39433111 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis | Q40553670 | ||
| The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos | Q40642168 | ||
| IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector | Q40863150 | ||
| The fate of individual myoblasts after transplantation into muscles of DMD patients | Q40883106 | ||
| Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation | Q41729529 | ||
| VEGF gene delivery to myocardium: deleterious effects of unregulated expression | Q41757138 | ||
| Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
| Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages | Q44971662 | ||
| Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation | Q45374311 | ||
| High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo | Q45855976 | ||
| VEGF gene therapy: stimulating angiogenesis or angioma-genesis? | Q45871293 | ||
| High-efficiency retroviral infection of primary myoblasts | Q46295799 | ||
| Myoblast-mediated gene transfer for therapeutic angiogenesis | Q46733913 | ||
| Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats | Q47412843 | ||
| Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow. | Q51661005 | ||
| Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. | Q52002244 | ||
| Myoblast transplantation for heart failure | Q58109127 | ||
| A method for using microspheres to measure muscle blood flow in exercising rats | Q70429304 | ||
| VEGF gene delivery to muscle: potential role for vasculogenesis in adults | Q77652479 | ||
| The range of adaptation by collateral vessels after femoral artery occlusion | Q80165425 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | angiogenesis | Q539568 |
| myoblast | Q1956694 | ||
| P304 | page(s) | 107-117 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia | |
| P478 | volume | 16 |
| Q37512327 | Cell and gene therapy approaches for cardiac vascularization |
| Q33586957 | Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels |
| Q26829783 | Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine |
| Q35851399 | Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification |
| Q33586324 | Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent. |
| Q35606014 | Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice |
| Q55395190 | Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. |
| Q36374351 | The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction |
| Q92546740 | Therapeutic vascularization in regenerative medicine |
| Q42141349 | Transplantation of vascular endothelial growth factor 165‑transfected endothelial progenitor cells for the treatment of limb ischemia |
Search more.